Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating HS-20004 for efficacy and safety in adults with Type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HS-20004

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED